Network

Networks

Network News

29 Mar 2016

2nd International Course on Viruses and Human Cancer, 01-09 July 2016, Istituto Pasteur Italia, Rome

Please click on the poster to download the pdf.

Deadline for application: May 15, 2016

Detailed program.

Application form.

Check the other courses of the Institut Pasteur International Network here.

29 Mar 2016

Zika and microcephaly: first trimester of pregnancy most critical

A new data analysis from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy. The study, led by Arnaud Fontanet (Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris) and Henri-Pierre Mallet (Bureau de Veille Sanitaire, Direction de la Santé, Papeete, Tahiti, French Polynesia) has been published in The Lancet* on March 15, 2016.

Read more on the Institut Pasteur website.

*: Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, Salje H, Van Kerkhove MD, Abadie V, Garel C, Fontanet A, Mallet HP, Association between Zika virus and microcephaly in French Polynesia, 2013-2015, The Lancet, March 15, 2016.

A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy. Their findings have been published in the journal The Lancet. - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-and-microcephaly-first-trimester-pregnancy-most-critical#sthash.51talNyG.dpufA new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy. Their findings have been published in the journal The Lancet. - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-and-microcephaly-first-trimester-pregnancy-most-critical#sthash.51talNyG.dpuf
A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy. Their findings have been published in the journal The Lancet. - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-and-microcephaly-first-trimester-pregnancy-most-critical#sthash.51talNyG.dpuf
A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy. Their findings have been published in the journal The Lancet. - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-and-microcephaly-first-trimester-pregnancy-most-critical#sthash.51talNyG.dpuf

29 Mar 2016

Institut Pasteur International Network: Call for applications - PhD scholarships of the doctoral Calmette and Yersin Program

The Department of International Affairs of the Institut Pasteur launches the call for applications for the PhD scholarship Calmette and Yersin Program. The Institut Pasteur International Network is looking for highly motivated individuals of all nationalities. It welcomes applications from qualified students who are passionate about addressing major global health challenges with innovative approaches based on interdisciplinary collaborations.
 
Applicants must hold, or anticipate receiving before enrolment, a university degree that would formally qualify them to enter a PhD or equivalent programme. The successful candidates will be based in one institute within the Institut Pasteur International Network, excluding metropolitan France.

The Institut Pasteur International Network comprises 33 institutes in 26 countries and offers unique opportunities to work in a common space for global sharing of technology, methods, expertise, resources and data throughout the five continents. Research areas include all themes developed in the laboratories of the Institut Pasteur International Network.
 

Proposed projects can be found at http://www.pasteur.fr/sites/www.pasteur.fr/files/phd_proposals_ao2016.pdf.

You can also consult the RIIP DATABASE, a unique reference base accessible by institutions, scientific staff and projects: http://databaseriip.pasteur.fr.
 

Fixed-term local contract with social charges for a duration of 3 years covers living expenses and insurance and a return air ticket per year.


Application deadline: July 31st, 2016
 

See all the information and eligibility criteria
Online applications exclusively on the dedicated website: http://bourses.pasteur-international.org
Contact: Eliane Coëffier, bourses-international@pasteur.fr

24 Mar 2016

Theme-based Research Scheme on Viral, Host and Environmental Determinants of Influenza Virus Transmission and Pathogenesis and Centre of Influenza Research Seminars, 8 April 2016

The Theme-based Research Scheme on Viral, Host and Environmental Determinants of Influenza Virus Transmission and Pathogenesis and the Centre of Influenza Research Seminars jointly organize the following serie of seminars:

Date: 8 April 2016 (Friday)
Time: 11:00 am to 12:30 pm
Venue: Mrs Chen Yang Foo Oi Telemedicine Centre, 2/F William MW Mong Block, LKS Faculty of Medicine , HKU

Seminar 1

“Case-control Study of Vaccine Effectiveness in Preventing Laboratory-confirmed Influenza Hospitalizations in Older Adults, United States, 2010-11”

by

Dr Fiona Havers, MD MHS
Influenza Division, US CDC, Atlanta

Biography:
Fiona Havers, MD, MHS, is a Medical Officer for the Influenza Prevention and Control Team, Epidemiology and Prevention Branch, Influenza Division, within the U.S. CDC's National Center for Immunization and Respiratory Diseases. Dr. Havers earned a Doctor of Medicine from the University of Washington. She completed training in internal medicine and infectious diseases at the Johns Hopkins University. She also obtained a Master’s of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and completed the Epidemic Intelligence Service training in the Influenza Division at CDC. She is board certified to practice internal medicine and infectious diseases, and is a staff physician at the Atlanta VA Medical Center. While at CDC, Dr. Havers’ research interests have focused on the epidemiology, prevention and treatment of influenza. Her current primary research focuses on influenza antiviral treatment as well as influenza vaccine effectiveness.

Seminar 2

“Increasing Seasonal Influenza Vaccination Coverage Among High Risk Groups in China: The Role of the Community Healthcare Worker”

by

Dr Carolyn Greene, MD
Influenza Division, US CDC, Beijing

Biography:
In September 2014, Dr. Carolyn Greene joined the U.S. CDC China Office as Director of the Influenza Program. Prior to moving to Beijing, Dr. Greene served as Deputy Commissioner for the Division of Epidemiology in New York City’s Department of Health and Mental Hygiene and as medical epidemiologist at the Centers for Disease Control and Prevention, first in the Respiratory Diseases Branch and then within the Global AIDS Program in Ethiopia. Dr. Greene completed internal medicine residency at University of California at San Francisco, medical school at Brown University and undergraduate studies at Yale University.  From 1990-1992, Dr. Greene taught English at Huazhong Normal University in Wuhan with the Yale-China Association. Currently, the US CDC influenza team in Beijing works closely with China CDC and other local partners to enhance prevention, detection and control of seasonal and novel influenza viruses in China. One priority is collecting local influenza disease burden and vaccine effectiveness data to promote seasonal influenza vaccination among  young children, older adults, pregnant women and healthcare workers.

Seminar 3

“Effects of Repeated Influenza Vaccination on Vaccine Effectiveness and Immunogenicity”

by
 
Dr Mark Thompson, PhD
Influenza Division, US CDC, Atlanta

Biography:
Mark Thompson, Ph.D. is an Epidemiologist in the Influenza Division of the US Centers for Disease Control and Prevention. He currently serves as Principal Investigator (PI) on multi-country investigations of influenza burden and vaccine effectiveness (VE), including studies focused on pregnant women, infants, older adults, and healthcare personnel; he previously served as PI for the US Flu VE Network. Mark received his doctorate in clinical and community psychology and completed post-doctoral fellowships in inter-disciplinary geriatric care and in statistics. Before joining CDC, he worked at Kaiser Permanente Northern California where he led clinical practice guideline initiatives and served as Program Director for Preventive Care. He has also spent time in the private sector developing information technologies and working with large employers (including Ford, General Motors, and AT&T) to improve disease management and preventive care for their employees.

ALL are welcome.

Kindly refer to trsflu@hku.hk for any queries.


Download the flyer here.

17 Mar 2016

Advanced Course on Antibiotics (AdCAb), October 10-21, 2016, Les Pensières, Annecy (France)

The Fondation Mérieux and the Institut Pasteur organizes an Advanced Course on Antibiotics (AdCAb).

When? 10-21 October 2016 (2 weeks)

Where? Les Pensières, Annecy (France)

What? The specific goal of AdCAb is to bring leaders and innovators in academics and industry together with highly trained scientists to share cutting-edge approaches and technologies for determination of antibacterial activity, detection of potential resistance mechanisms, antibiotic discovery, chemical optimization and usage that maximizes their utility and minimizes the development of resistance, including exploring public health, social, economic, political and ethical issues of antibiotic resistance.

Target? Early career scientists-assistant professors, new industry scientists, MDs, and postdoctoral research associates.

How to apply? Contact valentina.picot@fondation-merieux.org
Registration fees: EUR 4,900 (Reduced fees: EUR 2,900 for participants from academic and governmental institutions, and NGOs)

More details and programme outline: download the flyer.

15 Mar 2016

Asia Launch cum Seminar of the Report Recommendations of the Commission on a Global Health Risk Framework for the Future, March 13th, 2016

In order to cope with the risk of major outbreak of infectious diseases around the globe, the Commission on a Global Health Risk Framework for the Future of the U.S. National Academy of Medicine released its report "The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises" in january 2016 and recommended an investment of $4.5 billion per year to strengthen national public health systems, improve global response coordination and capabilities, and accelerate R&D. Professor Gabriel Leung, Commissioner and Dean of Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU), said, “Hong Kong and neighbouring Asian countries have experienced epidemics of infectious diseases, such as SARS, H1N1, H3N2, H7N9, etc. With the recent outbreak of seasonal influenza, both public and private medical services were overwhelmed due to the excessive demand for medical care, revealing deficiencies in global defenses against potential pandemics. It is most timely that we can have an in-depth discussion at this important occasion and offer recommendations to combat infectious diseases.”

In collaboration with the Centre for Medical Ethics and Law of HKU, the U.S. National Academy of Medicine and Bauhinia Foundation Research Centre, the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the School of Public Health, Li Ka Shing Faculty of Medicine of HKU hosted the Asia Launch cum Seminar of the Report Recommendations of the Commission on a Global Health Risk Framework for the Future at HKU on March 13, 2016 and presented the report in Asia for the first time.

For more details, please read the Li Ka Shing Faculty of Medicine press release.

(From left) Mr Terry Kaan, Director of Centre for Medical Ethics and Law, HKU, Professor Gabriel Leung, Dean of Li Ka Shing Faculty of Medicine, HKU, Dr Donald Li, Chairman of Bauhinia Foundation Research Centre, Mr Lau Ming-wai, Commission Funder and Vice Chairman of Bauhinia Foundation Research Centre, Dr Victor Dzau, President of the U.S. National Academy of Medicine, Professor Peter Mathieson, President and Vice-Chancellor of HKU, Professor Tan Chorh Chuan, President of National University of Singapore, Professor Lawrence Gostin, Director of WHO Collaborating Centre on Public Health Law and Human Rights, Mr Peter Sands, Former Group CEO of Standard Chartered PLC and Professor Michael Hor, Dean of the Faculty of Law, HKU took a group photo at the Asia Launch cum Seminar of the Report Recommendations of the Commission on a Global Health Risk Framework for the Future.

Photo courtesy: Li Ka Shing Faculty of Medicine, The University of Hong Kong

15 Mar 2016

Institut Pasteur International Network course: “Cell Biology and infection: Digital Image Processing/Analysis Tools for Quantitative Light Microscopy Imaging”, Hellenic Pasteur Institute, Athens, Greece

The Hellenic Pasteur Institute (Athens, Greece) organizes a 5-day practical course, from 4 to 8 July 2016, with objective to provide theoretical and practical training in basic and advanced concepts and methods of Bioimage informatics.

Deadline for application: April 30, 2016

The course Program will include:
1. Lectures focused on concepts and methodology for Processing/Analysis of Light Microscopy Digital data (images and videos) and selected topics of Cell Biology and Biology of Pathogen Host interaction.
2. Computer practical sessions on the quantitative analysis of microscopy image datasets using the open source software Icy and ImageJ/Fiji
3. Informal discussions and tutorials with experts in the field

The course is addressed to PhD students, post-doctoral fellows and research assistants, involved in research projects requiring fluorescence microscopy imaging and digital image processing/analysis. Eligible to submit applications are young scientists from any academic institution, but priority will be given to applicants from institutes members of the “Institut Pasteur International Network".

For more information, contact and application, please click on the poster below:

14 Mar 2016

International workshop on Leishmania and leishmaniasis: Immunology, Vaccine and Drug discovery/Therapy 9-13th Nov 2016, Institute Pasteur of Iran, Tehran

The Pasteur Institute of Iran in Tehran organizes the international workshop "Leishmania and leishmaniasis: Immunology, Vaccine and Drug discovery/Therapy", from 9 to 13 November 2016.

Deadline for application: 1st July 2016

Contact: Leishmania-wksp@pasteur.ac.ir

Poster1
Poster2

Application submission

Visa Application Form for Foreign Experts & Guests

The main aim of this course is to present a complete overview on recent advances in immunology, vaccine, vector biology, and drug discovery/therapy against leishmaniasis.The proposed course objectives will cover 6 different modules:

Module 1: Immunological aspects of experimental leishmaniasis (mouse model)
Cutaneous leishmaniasis
Visceral leishmaniasis

Module 2: Immunological and clinical aspects of Leishmaniasis in humans
Cutaneous leishmaniasis
Visceral leishmaniasis

Module 3: New advances in vaccine development
Dissecting different approaches for vaccine development against Leishmania
Use of adjuvants in the development of new vaccines against Leishmania

Module 4: Treatment and recent approaches for drug discovery for Leishmaniasis
Recent treatment of cutaneous and visceral leishmaniasis
Discovery of novel inhibitors against Leishmania infection and their efficacy using in vivo and in vitro models.

Module 5: Vector Biology and sandflies transmission
Recent advances in vector biology and their impact on disease transmission
The role of sandfly in disease exacerbation and protection

Module 6: Practical session
DNA integration in the Leishmania genome: an application for vaccine study and drug screening

 
Organizers:
Dr. Sima Rafati (Department of immunotherapy and Leishmania vaccine research, Pasteur Institute of Iran, Tehran, Iran)
Dr. Simona Stager (Institut Armand-Frappier, Université du Québec, Laval, Canada)

Speakers:
• Dessein A.
• Firooz A.
• Handjani F.
• Khamesipour A.
• Kropf P.
• Louzir H.
• Matlashewski G.
• Modabber F.
• Niknam H.
• No J.H.
• Papadopoulou B.
• Parvizi P.
• Peters N. C.
• Rafati S.
• Ready P.D.
• Salavati R.
• Smirlis P.
• Stager S.
• Tacchini-Cottier F.
• Taheri T.

 

Supported by: Pasteur Institute of Iran, Institut Pasteur Paris, DNDi, ICGE

08 Mar 2016

Seminar Croucher Foundation ASI: Frontier in Immunometabolism, Hong Kong, 19-21 April 2016

The Croucher Foundation Advanced Study Institutes invites graduate students, postdoctoral fellows and clinical researchers to join the seminar: Frontier in Immunometabolism

Date: 19-21 April 2016

Venue: Seminar Room 3, Hong Kong Jockey Club Building for Interdisciplinary Research, G/F, 5 Sassoon Road, Pokfulam, Hong Kong    

Organizer: Department of Medicine, The University of Hong Kong
Sponsor: The Croucher Foundation

SEMINAR INFORMATION
The Croucher Foundation Advanced Study Institute: Frontier in Immunometabolism focuses on crosstalk between immunity and metabolism, adipose tissue inflammation and adipokines, transcriptional and translational control of metabolic inflammation, role of innate and adaptive immunity in metabolism, omics and big data in metabolic research. Postgraduate students, postdoctoral fellows and early career researchers who would like to deepen the knowledge in immunometabolism are welcomed to this 3-day symposium.

Symposium Director: Professor Aimin Xu, HKU

Confirmed International lecturers: Profs Philipp Scherer (USA), Takashi Kadowaki (Japan), Jun Wang (China), Ajay Chawla (USA), Agnes Lehuen (France), Luke O’Neil (Ireland), David James (Australia) and Mirko Trajkovski (Switzerland), Bin Li (China), Feng Liu (USA), Weiping Han (Singapore), Jae-bum Kim (Korea), Dr. Zhao Wang (USA)

Local lecturers: Prof Zhongwei Cai, Dr. Gianni Panagiotou, Dr. Kenneth Cheng, Dr. Connie Woo

Abstract submission

Abstract submission deadline: 25 March 2016

Information & Registration form

Online registration deadline: 31 March 2016

Enquiry:
Croucher ASI: Frontier in Immunometabolism 2016 Secretariat
Department of Medicine
Email: 
kchan123@hku.hk

08 Mar 2016

Croucher Summer Course 2016: Advances in Immunology in Health and Disease (16-20 August 2016)

Organizer: Department of Medicine, The University of Hong Kong
Sponsor: The Croucher Foundation

COURSE INFORMATION
The Croucher Summer Course in 2016 focuses on the theme of Advances in Immunology in Health and Disease. This 5-day residential course aims for talented postgraduate students, postdoctoral fellows and early career researchers to deepen the fundamental knowledge in immunology and to understand the immunological aspects of major diseases. This course is limited to a maximum of 35 participants who will have the opportunities to learn and interact with world-renowned international scientists and local scientists through seminars and interactive discussion sessions.

Course Director: Professor Chak Sing Lau, HKU
Course Co-Director: Professor Tak Wah Mak, University of Toronto

Confirmed International lecturers: Profs Fred Alt, Yong-Jun Liu (USA), Tak Mak (Canada), Jeffrey Pollard (UK), Mikael Karlsson (Sweden), Marc Pelligrini (Australia) and Chen Dong (China)

Local lecturers: Profs Zhiwei Chen, Chak Sing Lau, Liwei Lu, Vera SF Chan, & Chun Kwok Wong (CUHK)

Language: All events are conducted in English.  Simultaneous translation will not be provided.

Application Deadline: 30 April 2016

Course Information & Registration Form: http://www.medic.hku.hk/croucher_summer_course_2016.htm

(50% registration discount for ICI 2016 attendees)

Enquiry:
Croucher Summer Course 2016 Secretariat
Email: croucher.sumschool.imm@hku.hk

Official website: http://projects.croucher.org.hk/page_collections/summer-courses 

08 Mar 2016

Asia Launch cum Seminar of the Report Recommendations of the Commission on a Global Health Risk Framework for the Future (GHRF) on 13 March 2016

On Sunday 13 March 2016 will be held the Asia Launch cum Seminar of the Report Recommendations of the Commission on a Global Health Risk Framework for the Future (GHRF) as co-organised by the U.S. National Academy of Medicine, the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the School of Public Health of The University of Hong Kong, The Centre for Medical Ethics and Law of The University of Hong Kong, and the Bauhinia Foundation Research Centre. The event will gather high-level stakeholders in health, finance, and policy from East and Southeast Asia to review the findings of the GHRF Commission and engage in productive discussion about next steps for reform.

The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises

13 March 2016 | 15:00-17:00 (followed by tea reception)
The University of Hong Kong | Large Moot Court, 2/F, Cheng Yu Tung Tower, Centennial Campus

Programme

Speakers include:

  • Victor J DZAU, Chair, International Oversight Group of the Commission; President, U.S. National Academy of Medicine
  • Lawrence GOSTIN, Commissioner; University Professor & Faculty Director, O’Neill Institute for National Global Health Law, Georgetown University; Director, WHO Collaborating Centre on Public Health Law & Human Rights
  • Gabriel M LEUNG, Commissioner; Co-Director of WHO Collaborating Centre for Infectious Disease Epidemiology and Control; Dean, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • Peter MATHIESON, President & Vice-Chancellor, The University of Hong Kong
  • Peter SANDS, Commission Chair; Former Group Chief Executive Officer, Standard Chartered PLC; Senior Fellow, Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School
  • TAN Chorh Chuan, Member, International Oversight Group of the Commission; President, National University of Singapore

Online registration is at https://hkuems1.hku.hk/hkuems/ec_hdetail.aspx?guest=Y&ueid=41531

Set up by the US National Academy of Medicine in 2015 following the large-scale outbreaks of SARS, H1N1, Ebola, MERS-CoV and other emerging infectious diseases, the Commission comprises 17 members from different countries and experts in finance, governance, R&D, health systems, and social sciences. The object of the Commission is to make recommendations for an effective global architecture for recognizing and mitigating the threat of epidemic infectious diseases, the process of which has been informed by 11 public workshops held across four continents as well as the solicitation of inputs from over 250 experts and stakeholders worldwide.

The Commission’s report, released on 13 January 2016 and presented to the 138th Meeting Session of the Executive Board of the World Health Organization thereafter, argued that pandemic prevention and response is essential to both national security and global economic stability—not just a matter of health. The Commission recommended an investment of $4.5 billion per year to strengthen national public health systems, improve global response coordination and capabilities, and accelerate R&D. Investment in these areas constitutes a sustainable global health risk framework that could protect populations from known and emerging infectious diseases and avert an estimated $60 billion per year in economic losses from pandemics.

07 Mar 2016

Institut Pasteur International Network: Watch the “Defeat Dengue” short film

"More than 130 countries worldwide are concerned by the resurgence of dengue fever. Today the disease affects hundreds of millions of people on all continents. Every year, 500,000 people are striken by severe dengue fever..."
 
DEFEAT DENGUE is a transversal program that brings together talents and skills of researchers working on different aspects of dengue, with the aim of jointly developing a number of innovative tools to control dengue disease. This ambitious project is made possible by the collaboration of several teams in Institut Pasteur Paris, in the Institut Pasteur International Network, and in several external institutions that have pledged to devote time and effort on this program.
 
 
Link to the video on Institut Pasteur's YouTube channel.
 
Defeat Dengue webpage.

07 Mar 2016

Zika: Confirmation of a causal link between the Zika virus and Guillain-Barré Syndrome

Using data collected in French Polynesia, researchers from the Institut Pasteur, the CNAM (Conservatoire national des arts et métiers), the Institut Louis Malardé, the French Polynesia Hospital Centre, and the Public Hospitals of Paris (AP-HP), have shown that infection by the Zika Virus (ZIKV) increases the likelihood of contracting Guillain-Barré Syndrome (GBS), a severe form of limb paralysis that is often accompanied by respiratory impairment. GBS has been observed in countries where the Zika epidemic is prolific. The research has been published in The Lancet on the 29th of February 2016.

Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A (corresponding author), Neil J, Ghawché F, Guillain-Barré Syndrome outbreak caused by ZIKA virus infection in French Polynesia, The Lancet, February 29, 2016.

More information on Institut Pasteur website.

Guillain-Barré Syndrome outbreak caused by ZIKA virus infection in French Polynesia, The Lancet, February 29, 2016 Cao-Lormeau VM*1, Blake A*2, Mons S3, Lastere S4, Roche C1, Vanhomwegen J5,6, Dub T2, Baudouin L3, Teissier A1, Larre P7, Vial AL8, Decam C9, Choumet V6, Halstead SK10, Prof Willison HJ10, Musset L11, Manuguerra JC5,6, Prof Despres P12, Prof Fournier E13, Mallet HP8, Musso D1, Prof Fontanet A2,14,15* (corresponding author), Neil J11*, Ghawché F7* - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-confirmation-causal-link-between-zika-virus-and-guillain-barre-syndrome#sthash.NvnM215K.dpuf
Guillain-Barré Syndrome outbreak caused by ZIKA virus infection in French Polynesia, The Lancet, February 29, 2016 Cao-Lormeau VM*1, Blake A*2, Mons S3, Lastere S4, Roche C1, Vanhomwegen J5,6, Dub T2, Baudouin L3, Teissier A1, Larre P7, Vial AL8, Decam C9, Choumet V6, Halstead SK10, Prof Willison HJ10, Musset L11, Manuguerra JC5,6, Prof Despres P12, Prof Fournier E13, Mallet HP8, Musso D1, Prof Fontanet A2,14,15* (corresponding author), Neil J11*, Ghawché F7* - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-confirmation-causal-link-between-zika-virus-and-guillain-barre-syndrome#sthash.NvnM215K.dpufMore on Institut Pasteur website.
Using data collected in French Polynesia, researchers from the Institut Pasteur, the CNAM (Conservatoire national des arts et métiers), the Institut Louis Malardé, the French Polynesia Hospital Centre, and the Public Hospitals of Paris (AP-HP), have shown that infection by the Zika Virus (ZIKV) increases the likelihood of contracting Guillain-Barré Syndrome (GBS), a severe form of limb paralysis that is often accompanied by respiratory impairment. (1) GBS has been observed in countries where the Zika epidemic is prolific. The research is published today in The Lancet. (2) - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-confirmation-causal-link-between-zika-virus-and-guillain-barre-syndrome#sthash.NvnM215K.dpuf
Using data collected in French Polynesia, researchers from the Institut Pasteur, the CNAM (Conservatoire national des arts et métiers), the Institut Louis Malardé, the French Polynesia Hospital Centre, and the Public Hospitals of Paris (AP-HP), have shown that infection by the Zika Virus (ZIKV) increases the likelihood of contracting Guillain-Barré Syndrome (GBS), a severe form of limb paralysis that is often accompanied by respiratory impairment. (1) GBS has been observed in countries where the Zika epidemic is prolific. The research is published today in The Lancet. (2) - See more at: http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-confirmation-causal-link-between-zika-virus-and-guillain-barre-syndrome#sthash.NvnM215K.dpuf